tetano
Editor, Senior Moderator
Obes Facts
. 2020 Jul 13;1-9.
doi: 10.1159/000510005. Online ahead of print.
Obesity and COVID-19: The Two Sides of the Coin
Dror Dicker[SUP] 1 2 [/SUP], Silvia Bettini[SUP] 3 4 [/SUP], Nathalie Farpour-Lambert[SUP] 3 5 [/SUP], Gema Fr?hbeck[SUP] 3 6 [/SUP], Rachel Golan[SUP] 3 7 [/SUP], Gijs Goossens[SUP] 3 8 [/SUP], Jason Halford[SUP] 3 9 [/SUP], Grace O'Malley[SUP] 3 10 [/SUP], Dana Mullerova[SUP] 3 11 [/SUP], Ximena Ramos Salas[SUP] 3 [/SUP], Maria N Hassapiou[SUP] 12 [/SUP], J?rn Sagen[SUP] 3 13 [/SUP], Euan Woodward[SUP] 3 [/SUP], Volkan Yumuk[SUP] 3 14 [/SUP], Luca Busetto[SUP] 3 4 [/SUP]
Affiliations
Abstract
The World Health Organization declared COVID-19, the infectious disease caused by the coronavirus SARS-CoV-2, a pandemic on March 12, 2020. COVID-19 is causing massive health problems and economic suffering around the world. The European Association for the Study of Obesity (EASO) promptly recognised the impact that the outbreak could have on people with obesity. On one side, emerging data suggest that obesity represents a risk factor for a more serious and complicated course of COVID-19 in adults. On the other side, the health emergency caused by the outbreak diverts attention from the prevention and care of non-communicable chronic diseases to communicable diseases. This might be particularly true for obesity, a chronic and relapsing disease frequently neglected and linked to significant bias and stigmatization. The Obesity Management Task Force (OMTF) of EASO contributes in this paper to highlighting the key aspects of these two sides of the coin and suggests some specific actions.
Keywords: Barrier to treatment; COVID-19; Obesity; Pandemic; SARS-CoV-2.
. 2020 Jul 13;1-9.
doi: 10.1159/000510005. Online ahead of print.
Obesity and COVID-19: The Two Sides of the Coin
Dror Dicker[SUP] 1 2 [/SUP], Silvia Bettini[SUP] 3 4 [/SUP], Nathalie Farpour-Lambert[SUP] 3 5 [/SUP], Gema Fr?hbeck[SUP] 3 6 [/SUP], Rachel Golan[SUP] 3 7 [/SUP], Gijs Goossens[SUP] 3 8 [/SUP], Jason Halford[SUP] 3 9 [/SUP], Grace O'Malley[SUP] 3 10 [/SUP], Dana Mullerova[SUP] 3 11 [/SUP], Ximena Ramos Salas[SUP] 3 [/SUP], Maria N Hassapiou[SUP] 12 [/SUP], J?rn Sagen[SUP] 3 13 [/SUP], Euan Woodward[SUP] 3 [/SUP], Volkan Yumuk[SUP] 3 14 [/SUP], Luca Busetto[SUP] 3 4 [/SUP]
Affiliations
- PMID: 32659766
- DOI: 10.1159/000510005
Abstract
The World Health Organization declared COVID-19, the infectious disease caused by the coronavirus SARS-CoV-2, a pandemic on March 12, 2020. COVID-19 is causing massive health problems and economic suffering around the world. The European Association for the Study of Obesity (EASO) promptly recognised the impact that the outbreak could have on people with obesity. On one side, emerging data suggest that obesity represents a risk factor for a more serious and complicated course of COVID-19 in adults. On the other side, the health emergency caused by the outbreak diverts attention from the prevention and care of non-communicable chronic diseases to communicable diseases. This might be particularly true for obesity, a chronic and relapsing disease frequently neglected and linked to significant bias and stigmatization. The Obesity Management Task Force (OMTF) of EASO contributes in this paper to highlighting the key aspects of these two sides of the coin and suggests some specific actions.
Keywords: Barrier to treatment; COVID-19; Obesity; Pandemic; SARS-CoV-2.